What Is Hyperthermia?
Temple University Hospital offers hyperthermia for patients with recurring, localized tumors who have failed prior conventional treatment, including radiation, surgery or chemotherapy. This treatment offers hope where previously there may have been limited or no options.
Hyperthermia is indicated for use in conjunction with radiation therapy to treat recurrent tumors located within a few centimeters of the surface of the body, such as tumors of the prostate or breast, head and neck, basal cell squamous cell skin cancers, and recurrent melanomas. Sarcomas in soft tissue or lymphatics may also be eligible. Hyperthermia can be delivered both superficially and interstitially.
Temple's radiation oncologists have more than 20 years' experience with hyperthermia.
What Does the Treatment Involve?
This treatment is entirely ambulatory and usually consists of three to five weeks of daily external radiation and two sessions of hyperthermia per week over the same time period, administered prior to the irradiation. The hyperthermia treatment lasts for 45 to 60 minutes and is very well tolerated.
For additional information, read this Hyperthermia Treatment brochure (PDF) from the device manufacturer.